Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP573168.RAEbeHDhtGlJSxQaQ5J9RdJkdHvWILNKBNwK5UNEI_fFU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP573168.RAEbeHDhtGlJSxQaQ5J9RdJkdHvWILNKBNwK5UNEI_fFU130_assertion type Assertion NP573168.RAEbeHDhtGlJSxQaQ5J9RdJkdHvWILNKBNwK5UNEI_fFU130_head.
- NP573168.RAEbeHDhtGlJSxQaQ5J9RdJkdHvWILNKBNwK5UNEI_fFU130_assertion description "[Furthermore, our data show that pharmacological concentrations of celecoxib may interfere with the proapoptotic action of R(+)-MA and anandamide, suggesting that cotreatment with COX-2 inhibitors could diminish glioma regression induced by these compounds.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573168.RAEbeHDhtGlJSxQaQ5J9RdJkdHvWILNKBNwK5UNEI_fFU130_provenance.
- NP573168.RAEbeHDhtGlJSxQaQ5J9RdJkdHvWILNKBNwK5UNEI_fFU130_assertion evidence source_evidence_literature NP573168.RAEbeHDhtGlJSxQaQ5J9RdJkdHvWILNKBNwK5UNEI_fFU130_provenance.
- NP573168.RAEbeHDhtGlJSxQaQ5J9RdJkdHvWILNKBNwK5UNEI_fFU130_assertion SIO_000772 15361550 NP573168.RAEbeHDhtGlJSxQaQ5J9RdJkdHvWILNKBNwK5UNEI_fFU130_provenance.
- NP573168.RAEbeHDhtGlJSxQaQ5J9RdJkdHvWILNKBNwK5UNEI_fFU130_assertion wasDerivedFrom befree-20150227 NP573168.RAEbeHDhtGlJSxQaQ5J9RdJkdHvWILNKBNwK5UNEI_fFU130_provenance.
- NP573168.RAEbeHDhtGlJSxQaQ5J9RdJkdHvWILNKBNwK5UNEI_fFU130_assertion wasGeneratedBy ECO_0000203 NP573168.RAEbeHDhtGlJSxQaQ5J9RdJkdHvWILNKBNwK5UNEI_fFU130_provenance.